The effect of peptide tyrosine tyrosine (PYY3–36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats

Abdel-Hamid Heba A.; Abdalla Mona M. I.; Zenhom Nagwa M.; Ahmed Rasha F.

doi:10.2478/enr-2019-0004

Endocrine Regulations (Jan 2019)

The effect of peptide tyrosine tyrosine (PYY3–36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats

Abdel-Hamid Heba A.,
Abdalla Mona M. I.,
Zenhom Nagwa M.,
Ahmed Rasha F.

Affiliations

Abdel-Hamid Heba A.: Physiology Department, Faculty of Medicine, Minia University, Misr-Aswan Road, El-Minia, Egypt
Abdalla Mona M. I.: Physiology Department, Faculty of Medicine, Minia University, Misr-Aswan Road, El-Minia, Egypt
Zenhom Nagwa M.: Biochemistry Department, Faculty of Medicine, Minia University, Misr-Aswan Road, El-Minia, Egypt
Ahmed Rasha F.: Biochemistry Department, Faculty of Medicine, Minia University, Misr-Aswan Road, El-Minia, Egypt

DOI: https://doi.org/10.2478/enr-2019-0004
Journal volume & issue: Vol. 53, no. 1
pp. 26 – 33

Abstract

Read online

Objective. The aim of the present study was to assess the effect of the PYY3–36, as a potential therapy for the type 2 diabetes mellitus (T2DM), induced by high fat diet (HFD) and an intraperitoneal (i.p.) administration of streptozotocin (STZ) in albino rats.

Published in Endocrine Regulations

ISSN: 1336-0329 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://sciendo.com/journal/ENR

About the journal

Abstract

Keywords